Weshalb die KemPharm-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 24. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2021 | 0,7500 | 7,8500 | 946,67% |
| 2 | 2024 | 5,3500 | 7,9500 | 48,60% |
| 3 | 2023 | 4,1900 | 5,3500 | 27,69% |
| 4 | 2017 | 44,8600 | 53,8400 | 20,02% |
| 5 | 2026 | 7,4000 | 7,9000 | 6,76% |
| 6 | 2025 | 7,9500 | 7,4000 | -6,92% |
| 7 | 2022 | 7,8500 | 4,1900 | -46,62% |
| 8 | 2018 | 53,8400 | 25,1200 | -53,34% |
| 9 | 2019 | 25,1200 | 7,9700 | -68,27% |
| 10 | 2016 | 277,1700 | 44,8600 | -83,82% |
| 11 | 2020 | 7,9700 | 0,7500 | -90,59% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2020 | 7,9700 | 0,7500 | -90,59% |
| 2 | 2016 | 277,1700 | 44,8600 | -83,82% |
| 3 | 2019 | 25,1200 | 7,9700 | -68,27% |
| 4 | 2018 | 53,8400 | 25,1200 | -53,34% |
| 5 | 2022 | 7,8500 | 4,1900 | -46,62% |
| 6 | 2025 | 7,9500 | 7,4000 | -6,92% |
| 7 | 2026 | 7,4000 | 7,9000 | 6,76% |
| 8 | 2017 | 44,8600 | 53,8400 | 20,02% |
| 9 | 2023 | 4,1900 | 5,3500 | 27,69% |
| 10 | 2024 | 5,3500 | 7,9500 | 48,60% |
| 11 | 2021 | 0,7500 | 7,8500 | 946,67% |